Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.32 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10699773 | 0.93 | CYP3A4 (0.38) | CYP3A4TDP1SLC9A1KCNA3KDM4E | |
| SCHEMBL6370293 | 0.93 | CYP3A4 (0.38) | CYP3A4TDP1SLC9A1KCNA3KDM4E | |
| SCHEMBL29179 | 0.88 | CYP3A4 (0.45) | CYP3A4TDP1KCNA3KDM4EGAA | |
| SCHEMBL8211513 | 0.85 | CYP3A4 (0.43) | CYP3A4TDP1KCNA3KDM4EGAA | |
| SCHEMBL28797563 | 0.85 | CYP3A4 (0.43) | CYP3A4TDP1KCNA3KDM4EGAA | |
| SCHEMBL7164452 | 0.85 | TDP1 (0.43) | CYP3A4TDP1KCNA3KDM4EGAA | |
| SCHEMBL2920316 | 0.85 | CYP3A4 (0.43) | CYP3A4TDP1KCNA3KDM4EGAA | |
| SCHEMBL689027 | 0.85 | TDP1 (0.43) | CYP3A4TDP1KCNA3KDM4EGAA | |
| SCHEMBL5838521 | 0.85 | TDP1 (0.43) | CYP3A4TDP1KCNA3KDM4EGAA | |
| SCHEMBL3930010 | 0.85 | CYP3A4 (0.43) | CYP3A4TDP1KCNA3KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111902359-A | Perhydropolysilazane composition and method for forming oxide film using same | 乔治洛德方法研究和开发液化空气有限公司 | 2020-11-06 | — | — | CN | disclosed |
| CN-100349905-C | Ligands for use in catalytic processes | EIDGENOESS TECH HOCHSCHULE (CH) | 2007-11-21 | — | — | CN | disclosed |
| US-20050107608-A1 | Ligands for use in catalytic processes | EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH ETHZ (CH) | 2005-05-19 | — | — | US | disclosed |
| CN-1599743-A | Ligands for use in catalytic processes | EIDGENOESS TECH HOCHSCHULE (CH) | 2005-03-23 | — | — | CN | disclosed |
| EP-1448575-A1 | LIGANDS FOR USE IN CATALYTIC PROCESSES | Eidgenössische Technische Hochschule (ETH) Zürich (CH) | 2004-08-25 | — | — | EP | disclosed |
| WO-2003048175-A1 | LIGANDS FOR USE IN CATALYTIC PROCESSES | EIDGENÖSSISCHE TECHNISCHE HOCHSCHULE ZÜRICH ETHZ (CH) | 2003-06-12 | — | — | WO | disclosed |
| EP-0568012-B1 | Bisphosphino alkanes | HOECHST AG (DE) | 1998-12-09 | — | — | EP | disclosed |
| EP-0568012-A2 | Bisphosphino alkanes | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107608-A1 | Ligands for use in catalytic processes | PNKP, ITPA, PLCG2 | CYP3A4 759/4885TDP1 2175/4885SLC9A1 3959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.